1. Banerjee R, Mohan M, Rejeski K, Puliafito B, Cirstea D, Kaur G, Midha S, McCaughan G, Kumar N, Mehra N, Bagal B, Raje N (2025). IVIG prophylaxis should be initiated following bispecific antibody therapy in multiple myeloma regardless of IgG levels. Blood Advances.

2. George GS, Singh A, Moirangthem R, Patil A, Pullat GB, Sagare S, Krishnatreya M, Mishra A, Sonwane R, Hosseini B, Chaturvedi A, Chaturvedi P, Dikshit R, Mhatre S (2025). Association of decayed, missing, filled teeth score with the risk for buccal mucosa cancer, stratified on tobacco and alcohol use: A multicenter case-control study From India. JCO Global Oncology. 11:e2500119

3. Pandit R, Yami Channaiah C, Lila AR, Karlekar M, Sarathi V, Memon SS, Barnabas R, Gupta T, Shah N, Bandgar T (2025). Long-term outcomes of pituitary radiotherapy and their predictive factors in childhood and adolescent-onset cushing disease. European Journal of Endocrinology.

Book Chapters
1. Chowdhury U. Khadilkar RJ. (2025). Targeting Innate Immunity: A New Door to Cancer Therapy. In: Ramteke, AS, Ramakrishnan SK, Agarwal R. (eds) Molecular Targets in Cancer Therapy. Springer, Singapore. Pp. 241-251. (ISBN: 978-9-81967-335-3)

2. Chhabra A, Tanwar KS (2025). Quality Considerations in Radiopharmaceuticals. In: Srivastava V, Vatsa R(eds.) Targeted Radiopharmaceuticals and Imaging Development Challenges and Opportunities. Royal Society of Chemistry. Pp. 435-452. (ISBN: 978-1-83767-327-8)

plprot is a plastid protein database which integrates data from large scale proteome analyses of different plastid types.These include etioplasts, chloroplasts, chromoplasts and the undifferentiated proplastid-like organelles of tobacco BY2 cells.

1. Simanshu DK, Xu R, Stice JP, Czyzyk DJ, Feng S, Denson JP, Riegler E, Yang Y, Zhang C, Donovan S, Smith BP, Abreu-Blanco M, Chen M, Feng C, Fu L, Rabara D, Young LC, Dyba M, Yan W, Lin K, Ghorbanpoorvalukolaie S, Larsen EK, Malik W, Champagne A, Parker K, Ju JH, Jeknic S, Esposito D, Turner DM, Lightstone FC, Wang B, Wehn PM, Wang K, Stephen AG, Maciag AE, Hata AN, Sinkevicius KW, Nissley DV, Wallace EM, McCormick F, Beltran PJ (2025). BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction. Science. 389(6758):409-415.

2. ACTREC Student Interview- Monika Jaiswal. Journal of Cell Science. 138 (14): jcs264297. 2025

In 1995, Tretinoin ( Vesanoid), a drug related to vitamin A was found to cause remission in patients with acute promyelocytic leukemia (APL).

2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)